Back

Tenascin-C provokes cardiac fibrosis and endothelial impairment in Duchenne Muscular Dystrophy

30 April 2022 (08:30 - 17:00)
Organised by: Logo
Congress Presentation Part of: Poster Session 2 Fibrosis CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2022 Council on Basic Cardiovascular Science

About the speaker

Photo
Ms Petra Lujza Szabo

Medical University of Vienna, Vienna (Austria)

69 More presentations in this session

Presentation thumbnail
Evidence of Sialylation pathways alteration in peripheral blood of Brugada Syndrome patients
Mrs A. Tarantino (Milan, IT)
Abstract
Presentation thumbnail
Autopsy and genetic characterization of juvenile sudden cardiac arrest and death: the ToRSADE experience
Doctor V. Spinelli (Florence, IT)
Abstract
Presentation thumbnail
Paracrine signal emanating from stressed cardiomyocytes aggravates inflammatory microenvironment in diabetic cardiomyopathy
Miss N. Kaur (Manchester, GB)
Abstract
Presentation thumbnail
Immunomodulatory effect of different statin regimens on regulatory T-cells among patients with acute coronary syndrome: a systematic review and network meta-analysis of randomized clinical trials
Doctor E. Greca (Miami, US)
Abstract
Presentation thumbnail
Dissection of the role of microRNAs in cardiac fibrosis through functional genomics screenings
Doctor M. Mano (Coimbra, PT)
Abstract

Access the full session

Session thumbnail
Poster Session 2

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2022

30 April 2022 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Increased Tenascin-C expression contributes to cardiac dysfunction and fibrosis in Duchenne muscular dystrophy
28 August 2022
thumbnail
Congress Presentation
Conditional ablation of SDF-1/CXCL12 in smooth muscle cells leads to severe cardiac hypertrophy and aortic valve stenosis
3 September 2019
thumbnail
Congress Presentation
Cardioprotective potential of plasminogen activator inhibitor-1 (PAI-1) in human inflammatory cardiomyopathy
29 June 2021
thumbnail
Congress Presentation
The non-steroidal mineralocorticoid receptor antagonist finerenone prevents structural cardiac remodeling
3 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources